Your browser is no longer supported. Please, upgrade your browser.
Settings
AKRX Akorn, Inc. daily Stock Chart
AKRX [NASD]
Akorn, Inc.
Index- P/E- EPS (ttm)-3.16 Insider Own1.80% Shs Outstand127.65M Perf Week-51.38%
Market Cap24.50M Forward P/E0.46 EPS next Y0.20 Insider Trans0.70% Shs Float118.77M Perf Month-62.50%
Income-401.30M PEG- EPS next Q-0.05 Inst Own73.20% Short Float10.04% Perf Quarter-92.24%
Sales721.30M P/S0.03 EPS this Y44.30% Inst Trans3.33% Short Ratio0.86 Perf Half Y-97.55%
Book/sh-0.15 P/B- EPS next Y333.33% ROA-31.30% Target Price- Perf Year-97.69%
Cash/sh0.27 P/C0.34 EPS next 5Y- ROE-203.60% 52W Range0.09 - 5.46 Perf YTD-94.00%
Dividend- P/FCF- EPS past 5Y-35.65% ROI-11.80% 52W High-98.35% Beta1.10
Dividend %- Quick Ratio0.30 Sales past 5Y4.20% Gross Margin40.70% 52W Low0.00% ATR0.05
Employees2227 Current Ratio0.50 Sales Q/Q23.40% Oper. Margin-51.20% RSI (14)27.63 Volatility38.15% 21.79%
OptionableYes Debt/Eq- EPS Q/Q-207.30% Profit Margin-55.60% Rel Volume2.44 Prev Close0.09
ShortableYes LT Debt/Eq- EarningsMar 05 BMO Payout- Avg Volume13.85M Price0.09
Recom3.00 SMA20-62.05% SMA50-69.56% SMA200-95.81% Volume0 Change0.00%
Mar-20-19Initiated SunTrust Hold
Oct-17-18Upgrade Piper Jaffray Neutral → Overweight
Jul-25-18Reiterated RBC Capital Mkts Sector Perform $25 → $27
Apr-25-17Downgrade Piper Jaffray Overweight → Neutral
Apr-25-17Downgrade Jefferies Buy → Hold
Apr-25-17Downgrade Gabelli & Co Buy → Hold
Mar-10-17Reiterated WallachBeth Hold $22 → $25
Dec-01-16Initiated Goldman Sell
Nov-07-16Downgrade WallachBeth Buy → Hold $40 → $22
Nov-07-16Downgrade BofA/Merrill Buy → Underperform
Nov-04-16Downgrade RBC Capital Mkts Outperform → Sector Perform $37 → $24
Sep-15-16Upgrade Piper Jaffray Neutral → Overweight
Aug-05-16Reiterated WallachBeth Buy $39 → $40
Aug-05-16Downgrade Deutsche Bank Buy → Hold $33 → $33
Aug-02-16Downgrade Raymond James Outperform → Mkt Perform
Mar-18-16Reiterated Deutsche Bank Buy $40 → $33
Feb-12-16Reiterated RBC Capital Mkts Outperform $52 → $37
Dec-02-15Upgrade Nomura Neutral → Buy
Sep-29-15Initiated Nomura Neutral
Sep-09-15Initiated JMP Securities Mkt Perform
May-28-20 11:14AM  
May-26-20 12:42PM  
May-22-20 01:37PM  
May-21-20 12:21PM  
08:01AM  
07:56AM  
May-20-20 11:52PM  
08:12PM  
May-11-20 05:14PM  
Apr-27-20 06:17PM  
Apr-07-20 02:08PM  
Apr-02-20 03:59PM  
Apr-01-20 06:20AM  
Feb-29-20 07:20AM  
Feb-26-20 04:58PM  
Feb-19-20 09:55AM  
Feb-12-20 05:29PM  
Feb-10-20 07:00AM  
Jan-31-20 07:12AM  
Jan-14-20 12:41PM  
Dec-19-19 09:26AM  
Dec-18-19 02:52PM  
Dec-16-19 07:51AM  
Dec-11-19 01:54PM  
Dec-02-19 08:00AM  
Nov-28-19 09:00AM  
Nov-26-19 08:36AM  
Nov-19-19 04:54PM  
Nov-12-19 08:27AM  
Nov-11-19 07:03AM  
Nov-07-19 08:22AM  
Nov-05-19 07:00PM  
Nov-02-19 05:22AM  
Oct-31-19 08:35AM  
07:00AM  
Oct-24-19 10:32AM  
Oct-17-19 09:00AM  
Oct-15-19 07:50AM  
Oct-14-19 04:25PM  
01:05PM  
Sep-29-19 08:36AM  
Aug-26-19 01:35PM  
Aug-14-19 03:30PM  
Aug-07-19 10:30PM  
Aug-02-19 07:24AM  
Aug-01-19 08:55AM  
Jul-29-19 11:33AM  
Jul-25-19 10:33AM  
Jul-11-19 04:32PM  
Jun-28-19 07:00AM  
Jun-27-19 11:20AM  
Jun-25-19 11:00AM  
10:32AM  
09:41AM  
08:17AM  
08:08AM  
07:44AM  
07:35AM  
Jun-14-19 07:01AM  
May-30-19 07:59AM  
May-21-19 07:40AM  
May-20-19 04:05PM  
08:01AM  
May-16-19 01:08AM  
May-12-19 09:49PM  
May-08-19 09:24AM  
May-07-19 08:35AM  
07:24AM  
07:05AM  
Apr-24-19 09:14AM  
Apr-22-19 07:00PM  
03:00PM  
02:27PM  
12:58PM  
11:09AM  
09:58AM  
09:28AM  
Apr-19-19 06:00PM  
05:36PM  
Apr-18-19 05:00PM  
04:05PM  
01:47PM  
01:40PM  
11:51AM  
10:57AM  
Apr-17-19 08:41PM  
Apr-16-19 04:45PM  
10:57AM  
Apr-15-19 05:31PM  
01:56PM  
10:20AM  
08:45AM  
Apr-12-19 03:30PM  
03:00PM  
09:55AM  
Apr-11-19 03:45PM  
Apr-10-19 10:21PM  
Apr-09-19 08:31PM  
10:48AM  
Apr-08-19 05:27PM  
Akorn, Inc., a specialty pharmaceutical company, develops, manufactures, and markets generic and branded prescription pharmaceuticals, over-the-counter (OTC) consumer health products, and animal health pharmaceuticals in the United States and internationally. The company operates in two segments, Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment offers generic and branded prescription pharmaceuticals in various dosage forms, including sterile ophthalmics, injectables, and inhalants; and non-sterile oral liquids, topicals, nasal sprays, and otics. Its primary products include Akten, a topical ocular anesthetic gel; AzaSite, an antibiotic used to treat bacterial conjunctivitis; Cosopt, Cosopt PF, Betimol, and Zioptan, which are used in the treatment of glaucoma; and Xopenex inhalation solution used in the treatment or prevention of bronchospasm. The Consumer Health segment manufactures and markets OTC products for the treatment of dry eye under the TheraTears brand. It also markets other OTC consumer health products comprising Mag-Ox, a magnesium supplement; and the Diabetic Tussin line of cough and cold products. In addition, this segment offers a portfolio of animal health products, such as Anased and VetaKet veterinary sedatives; Tolazine and Yobine sedative reversing agents; and Butorphic, a pain reliever. Further, the company sells its products to wholesale distributors. Akorn, Inc. was founded in 1971 and is headquartered in Lake Forest, Illinois. On May 20, 2020, Akorn, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Young ChristopherEVP, Global OperationsMar 13Sale0.5654,62930,59269,273Mar 13 08:49 PM
Kafer JonathanEVP & Chief Commercial OfficerMar 06Sale1.0211,08811,310193,257Mar 10 09:25 PM
MEYER STEVEN JDirectorMar 03Buy0.9915,00014,850145,225Mar 04 06:39 PM
MEYER STEVEN JDirectorMar 02Buy1.0885,00091,800130,225Mar 04 06:39 PM
MEYER STEVEN JDirectorAug 15Buy2.5010,00025,000183,154Aug 15 03:56 PM
MEYER STEVEN JDirectorAug 14Buy2.7010,00027,000173,154Aug 15 03:56 PM